The Ethena (ENA) market activity gained momentum in the most recent trading session. Volume growth was sharp, and buyers became more involved, indicating more robustThe Ethena (ENA) market activity gained momentum in the most recent trading session. Volume growth was sharp, and buyers became more involved, indicating more robust

Can Ethena (ENA) Hold $0.207 Support? Analysts Eye 5-7% Crash Ahead

2025/12/30 17:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The Ethena (ENA) market activity gained momentum in the most recent trading session. Volume growth was sharp, and buyers became more involved, indicating more robust engagement in the short term.

As of press time, Ethena (ENA) is trading at $0.2083, which represents a 0.49% increase in 24 hours. Trading volume increased 61.7% to $147.95 million. The token is still lower this week, despite the daily gain, recording a decline at 0.54%.

Source: CoinMarketCap

Ethena Bearish Continuation Triggered Below $0.2062

Analyst Umair Crypto highlighted that ENA continues to trade in bearish flag targets on the daily chart. He pointed out that price action still closely adheres to the trajectory. The deficiency in the deviation maintains the bearish setup.

Similar pressure is seen in shorter periods. Analysts found a new bearish flag formation on the four-hour chart. Momentum has become central in the determination of direction. The relative strength index trendline is the key indicator that Umair Crypto identified.

Further weakness could be validated by a broken RSI support. The analyst further stated that a four-hour candle below the 50 simple moving average of $0.2073 would give a better argument on the bearish side. A close below $0.2062 would be an obvious signal of continuation.

Source: X

With the arrangement validated, ENA may encounter a pullback of 5% to 7%. The downside targets are within a range of $0.195 to $0.192. This is the second area of interest for short sellers in case of momentum loss. Traders are also monitoring $0.2018 in case of any downward trend. An increase in volume there could be an indication of a local reversal attempt.

Crypto Coral, another analyst, mentioned that ENA remains in an upwards trendline. The building exhibits great lows as they develop. This implies that buyers are active around support areas.

A trendline bounce can bring the price to a major resistance zone higher than the current price. If the buying strength establishes itself, such a situation would test the bearish outlook. Until then, the price is able to hold above the four-hour 50 SMA, which continues to put pressure on.

Source: X

ENA Open Interest Rises 2%, Signaling New Positions

According to CoinGlass data, ENA trading volume has increased by 87.50% to $483.71 million. Open interest increased 2.04% to $305.89 million, which indicated new positions in the market. The Ethena OI-weighted funding rate stood at 0.0032%.

Source: CoinGlass

The liquidation data is moderate. Total liquidations stood at $499.16K over the last 24 hours. The long liquidations amounted to $358.04K, and the short liquidations amounted to $141.12K. The figures indicate active positioning as traders await the next move of Ethena.

Source: CoinGlass

Also Read: Chainlink (LINK) gains momentum, Elliott Wave signals continued upside toward $16.60

Market Opportunity
Ethena Logo
Ethena Price(ENA)
$0.10205
$0.10205$0.10205
-4.59%
USD
Ethena (ENA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09